Compare LOAN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LOAN | RFL |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Real Estate |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9M | 61.1M |
| IPO Year | 1999 | 2017 |
| Metric | LOAN | RFL |
|---|---|---|
| Price | $4.44 | $1.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.3K | ★ 91.0K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | ★ 9.96% | N/A |
| EPS Growth | 2.08 | ★ 28.28 |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $9,688,641.00 | $917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | $12.69 | ★ N/A |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $4.24 | $1.12 |
| 52 Week High | $6.05 | $3.19 |
| Indicator | LOAN | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 65.63 |
| Support Level | $4.29 | $1.41 |
| Resistance Level | $4.59 | $1.63 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 76.45 | 71.25 |
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.